知名药企董事长逝世，年仅60岁，旗下上市公司市值33亿元

Core Viewpoint - The passing of Yin Zhenglong, the controlling shareholder and chairman of Anhui Shanhe Pharmaceutical Auxiliary Co., Ltd., is a significant event for the company, which may lead to changes in leadership but is not expected to disrupt its operations [1][3]. Group 1: Company Leadership - Yin Zhenglong passed away on August 26, 2025, at the age of 60, and had been the chairman and general manager since the company's inception [3][5]. - He held 63,057,454 shares, representing 26.90% of the total shares, making him the controlling shareholder [3]. - The company announced that the board's functionality will remain intact, and the management team will continue its operations without interruption [3]. Group 2: Company Operations - Following Yin Zhenglong's death, the company will conduct a board election to fill the chairman position, with current director and general manager Song Daocai temporarily assuming the role [3][5]. - The company reported a revenue of 471 million yuan for the first half of 2025, a year-on-year increase of 4.65%, while the net profit attributable to shareholders was approximately 93 million yuan, a decrease of 2.61% [8]. - Basic earnings per share were reported at 0.40 yuan, down 2.44% year-on-year [8]. Group 3: Company Background - Anhui Shanhe Pharmaceutical Auxiliary Co., Ltd. was established in April 2001 and specializes in the production, research, and sales of new pharmaceutical excipients, holding a leading position in the domestic market [8]. - The company was listed on the Shenzhen Stock Exchange's Growth Enterprise Market in May 2015 [8]. Group 4: Recent Developments - The company's official website has been changed to a black-and-white page, indicating a period of mourning [6]. - Yin Zhenglong had recently chaired a shareholders' meeting on August 18 and a board meeting on the morning of August 26, just hours before his passing [5].